We have better drugs than ever. That is a good thing. But here is the rub: most people with psoriatic arthritis still feel like crap. Joint swelling, deep fatigue, pain that does not quit. Why? Because minimal disease activity remains a theoretical goal for too many patients.
Maybe the current treatment isn’t the right fit. Maybe nobody asked what actually keeps you up at night.
The Goal: Minimal Disease Activity
Doctors use a “treat-to-target” strategy. Simple logic. Pick a goal, monitor it, tweak the meds until you hit that number.
For most, the target is Minimal Disease Activity, or MDA. It requires meeting 5 out of specific 7 criteria based on clinical tests and your own report on how you feel.
“It fits well with the treat-to-target – assess regularly, define the goal,” says M. Elaine Husni MD MPH, a rheumatology director at Cleveland Clinic. “Adjust therapy when the goal is not met.”
Not every doctor cares strictly about MDA. Some rely on a handshake physical exam. Or just asking, “Are you okay?” Rebecca Gordon MD of UCHealth says tolerating medication is its own metric, one that sits outside the MDA score.
Real control looks like this:
– No swollen or painful joints.
– Little to no active skin psoriasis.
– Entheses (where tendons hit bone) do not hurt.
– No sausage-like swelling in fingers or toes.
– Brain fog and fatigue lift off.
Eric Ruderman MD from Northwestern Medicine says function matters most. If you can’t do the things you love, the score on a clipboard is useless.
The Red Flags
Are you accepting mediocrity as a medical outcome?
Persistent swelling is a bad sign. So is morning stiffness that drags on all day. If you are cycling through steroid bursts to manage flares, you are losing. Worsening nails or skin count too.
But wait. Pain does not always equal active arthritis. You could have a herniated disc causing the ache. Dr. Gordon recommends ultrasound or MRI to separate arthritis inflammation from other structural issues.
“If you go after a global measure but the thing bothering the patient isn’t better you haven’t achieved your target,” Ruderman says. “Ask them. What sucks? Joints? Skin? Your Achilles?”
Why You Can’t Just Cope
This is not just about comfort. It is about your long-term health.
Leaving low-grade inflammation untreated accelerates joint damage. It also hikes your cardiovascular risk. Dr. Gordon points to the link with lipids and blood pressure.
“If you settle sometimes disease with low grade symptoms can continue,” Husni says. “Lead to disability over time.”
Here is a tricky part. Biologics might prevent bone damage even if symptoms linger. But staying on a drug that only works partially? That risks a bad switch later when you change therapies.
Why live with limitations when the tools to remove them exist?
Make Them Fix It
Silence is dangerous. If the plan fails, talk.
Dr. Husni suggests a diary. Weekly entries. Log the pain spikes, the weird twinges. Show the data. It forces the physician to see patterns they might miss in a five-minute consult.
Ask between appointments too. Rheum schedules are brutal. Use messaging platforms. Email. Get your concerns in writing.
Walk into that next exam and ask bluntly: Am I at my target?
“Say, These are the elements I’m not happy with. What do we do?” Ruderman commands. “Don’t be afraid.”
It is your body. Your job. Make sure the plan works.
The Bottom Line
Minimal disease activity should be the baseline not the stretch goal. Unchecked activity destroys joints. It harms the heart.
Track the symptoms. Push back on “wait and see.” Demand a plan that actually lets you live.
Sources include Journal of Rheumatology (Jan 2018), Mayo Clinic updates, and National Psoriasis Foundation classifications.
Medical Reviewer: Sian Yik Lim MD. Author: Quinn Phillips.
